DLBCL
Clinical trials for DLBCL explained in plain language.
Never miss a new study
Get alerted when new DLBCL trials appear
Sign up with your email to follow new studies for DLBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New weapon against tough cancers: first human test of BAFF-R CAR-T therapy begins
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy, called BAFF-R CAR-T, for people with B-cell lymphomas that have come back or not responded to other treatments. The main goals are to check if the treatment is safe and to find the best dose. Researchers will als…
Matched conditions: DLBCL
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Could your gut bugs predict cancer treatment success?
Knowledge-focused Not yet recruitingThis study aims to understand if the types of bacteria in a patient's gut (the microbiome) influence how well they respond to a lymphoma drug called glofitamab. Researchers will observe 30 patients with a specific type of lymphoma (DLBCL) who are already scheduled to receive this…
Matched conditions: DLBCL
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC